Pilot Proof of Mechanism Study of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPPs), in Patients With Pancreatic Cancer
Summary
The purpose of this pilot study is to assess the biochemical and immunomodulatory effects of BXCL701 in pancreatic cancer.
General Information
NCT#: NCT04123574
Study ID: BXCL701-001
Trial Phase: Pilot
Trial Sponsor: BioXcel Therapeutics Inc, IQVIA Biotech
Therapies Used in This Trial: BXCL701